SupremeToday Landscape Ad
Back
Next
Judicial Analysis Court Copy Headnote Facts Arguments Court observation
Listen Audio Icon Pause Audio Icon
judgment-img

DELHI HIGH COURT
PRATHIBA M.SINGH
Sanofi India Limited – Appellant
Versus
Ridley Life Science Private Limited – Respondent


Table of Content
1. defendant's non-compliance with injunction. (Para 2 , 4 , 5)
2. plaintiff's evidence of habitual infringement. (Para 3 , 6 , 10)
3. recognition of trademark rights and history of marks. (Para 7 , 8 , 9 , 12)
4. strict action required against habitual infringers. (Para 11 , 14 , 18)
5. court's directive for financial penalty and compliance. (Para 15 , 16 , 20 , 22)

JUDGMENT

Prathiba M. Singh, J. (Oral)--This hearing has been done through hybrid mode.

I.A. 2195/2022(u/O XXXIX Rule 2A CPC)

2. The present application has been moved by the Plaintiff on the ground that the injuncted products `CONCIFLAM' and `CORIFLAM', are being sold by the Defendant, despite the injunction order passed on 31st May, 2021.

3. On the last date of hearing i.e., 1st April, 2022, this Court had directed that the Directors of the Defendant-Company Mr. Rajesh Bansal and Rakesh Bansal, as also Mr. Ram Kumar Gautam, shall remain present in Court. The said order reads as under:

    "2. This is an application filed on behalf of the Plaintiff under Order XXXIX Rule 2A CPC. The grievance of the Plaintiff is that the Defendants are continuously violating the order dated 31st May, 2021 passed by this Cour

Click Here to Read the rest of this document
1
2
3
4
5
6
7
8
9
10
11
SupremeToday Portrait Ad
supreme today icon
logo-black

An indispensable Tool for Legal Professionals, Endorsed by Various High Court and Judicial Officers

Please visit our Training & Support
Center or Contact Us for assistance

qr

Scan Me!

India’s Legal research and Law Firm App, Download now!

For Daily Legal Updates, Join us on :

whatsapp-icon telegram-icon
whatsapp-icon Back to top